Secondary metabolite profiling using HR-LCMS, antioxidant and anticancer activity of
Antioxidant
Bacillus cereus
HER2
HRLC-MS
MTT assay
Molecular docking
Journal
Biotechnology reports (Amsterdam, Netherlands)
ISSN: 2215-017X
Titre abrégé: Biotechnol Rep (Amst)
Pays: Netherlands
ID NLM: 101637426
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
12
02
2024
revised:
24
04
2024
accepted:
25
04
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
22
5
2024
Statut:
epublish
Résumé
Novel anticancer drugs of natural origin have increased tremendously due to the resistance of multiple chemotherapeutic drugs in breast cancer therapy and their high toxicity with undesirable side effects. The study investigates the bioactivity of secondary metabolites derived from
Identifiants
pubmed: 38774767
doi: 10.1016/j.btre.2024.e00842
pii: S2215-017X(24)00015-8
pmc: PMC11107235
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e00842Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The author's declare that no conflict of interest in the present manuscript.